GE HealthCare Technologies (GEHC) Financial Analysis & Valuation | Quarter Chart
Company facts
Reported company information and share structure.
| Market Cap | $28.97B | Exchange | NASDAQ |
| Sector | Healthcare | Industry | Medical - Healthcare Information Services |
| Country | US | CEO | Peter J. Arduini |
| IPO Date | 2022-12-15 | CAGR | 3.65% |
| Employees | 54,000 | Website | www.gehealthcare.com |
| Div. Yield | 0.06% | Payout Ratio | 4% |
| Buy Back Yield | 0.58% | Total Yield | 0.64% |
Key metrics
Reported fundamentals and market-derived technical indicators.
| EV | $34.78B | P/E | 14.06 | Forward P/E | 12.78 | PEG | -0.68 |
| P/S | 3.44 | P/B | 6.35 | P/CF | 49.2 | P/FCF | 78.17 |
| Sales | $20.24B | Sales 1Y | 1.39% | Sales 3Y | 6.33% | Sales 5Y | — |
| EPS | $4.56 | EPS 1Y | -29.3% | EPS 3Y | -4.43% | EPS 5Y | — |
| Sales QoQ | 3.2% | EPS QoQ | 45.88% | Sales QoQ Avg | 1.65% | EPS QoQ Avg | 25.2% |
| Gross Margin | 42.9% | Operating Margin | 12.7% | Profit Margin | 7.86% | ROCE | 8.88% |
| ROA | 4% | ROE | 15% | Altman Z Score | 1.69 | Piotroski Score | 5 |
| Current Ratio | 1.02 | Quick Ratio | 0.72 | Cash Ratio | 0.25 | Op. CF Ratio | -0.06 |
| Debt/Equity | 0.92 | Debt/Assets | 0.27 | Lt Debt/Equity | 0.92 | Lt Debt/Cap. | 0.48 |
| Intrst Cov. | 5.9 | Inventory Turnover | 4.65 | Asset Turnover | 0.54 | Receivables Turnover | 5.22 |
| Enterprise Value | $34.78B | P/E Ratio | 14.06 |
| Forward P/E | 12.78 | PEG Ratio | -0.68 |
| P/S Ratio | 3.44 | P/B Ratio | 6.35 |
| P/CF Ratio | 49.2 | P/FCF Ratio | 78.17 |
| EPS | $4.56 | EPS Growth 1Y | -29.3% |
| EPS Growth 3Y | -4.43% | EPS Growth 5Y | — |
| Revenue Growth 1Y | 1.39% | Gross Margin | 42.9% |
| Operating Margin | 12.7% | Profit Margin | 7.86% |
| ROE | 15% | ROA | 4% |
| ROCE | 8.88% | Current Ratio | 1.02 |
| Quick Ratio | 0.72 | Cash Ratio | 0.25 |
| Debt/Equity | 0.92 | Interest Coverage | 5.9 |
| Altman Z Score | 1.69 | Piotroski Score | 5 |
GE HealthCare Technologies (GEHC) valuation & financials
GE HealthCare Technologies (GEHC) has a market capitalization of $28.97B and trades at a price-to-earnings ratio of 14.1. It operates in the Healthcare sector (Medical - Healthcare Information Services).
GE HealthCare Technologies's revenue grew +1.4% over the last year.
GE HealthCare Technologies's next earnings report is scheduled for November 4, 2026 before market open (provider scheduled date); analysts estimate EPS of $1.21. Check the earnings calendar to see all companies reporting this week.
Compare with other Healthcare companies: Eli Lilly (LLY) · Johnson & Johnson (JNJ) · AbbVie (ABBV) · Merck (MRK) · UnitedHealth (UNH) · Roche (ROG.SW)